Mahesh Shrestha

1.4k total citations
27 papers, 1.0k citations indexed

About

Mahesh Shrestha is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mahesh Shrestha has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mahesh Shrestha's work include Acute Myeloid Leukemia Research (9 papers), Asthma and respiratory diseases (4 papers) and Vector-borne infectious diseases (3 papers). Mahesh Shrestha is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Asthma and respiratory diseases (4 papers) and Vector-borne infectious diseases (3 papers). Mahesh Shrestha collaborates with scholars based in United States, United Kingdom and Japan. Mahesh Shrestha's co-authors include Allen C. Steere, Robert L. Grodzicki, James E. Hayes, James C. Mulloy, Mark Wunderlich, Benjamin Mizukawa, Fu‐Sheng Chou, Shan Lin, Rajeev Singh and David L. Morgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Immunology.

In The Last Decade

Mahesh Shrestha

27 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahesh Shrestha United States 17 307 246 234 217 159 27 1.0k
Sara Passos Brazil 14 135 0.4× 134 0.5× 140 0.6× 56 0.3× 41 0.3× 20 953
Takanobu Kurashige Japan 18 225 0.7× 100 0.4× 23 0.1× 124 0.6× 92 0.6× 86 1.1k
Víctor Llorenç Spain 21 128 0.4× 98 0.4× 51 0.2× 45 0.2× 135 0.8× 76 1.4k
Guadalupe Hernández‐Pacheco Mexico 19 158 0.5× 42 0.2× 33 0.1× 107 0.5× 47 0.3× 41 950
Herbert B. Lindsley United States 14 143 0.5× 129 0.5× 37 0.2× 38 0.2× 60 0.4× 23 861
Caroline A. Lindemans Netherlands 21 243 0.8× 767 3.1× 15 0.1× 192 0.9× 192 1.2× 118 1.8k
Deniz Çağdaş Türkiye 18 181 0.6× 109 0.4× 11 0.0× 121 0.6× 55 0.3× 120 974
J.M. Garnier France 14 481 1.6× 39 0.2× 45 0.2× 58 0.3× 15 0.1× 41 964
Ismé de Kleer Netherlands 11 362 1.2× 147 0.6× 13 0.1× 96 0.4× 91 0.6× 15 1.4k
Donna Smith United States 13 165 0.5× 286 1.2× 126 0.5× 28 0.1× 80 0.5× 21 1.0k

Countries citing papers authored by Mahesh Shrestha

Since Specialization
Citations

This map shows the geographic impact of Mahesh Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahesh Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahesh Shrestha more than expected).

Fields of papers citing papers by Mahesh Shrestha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahesh Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahesh Shrestha. The network helps show where Mahesh Shrestha may publish in the future.

Co-authorship network of co-authors of Mahesh Shrestha

This figure shows the co-authorship network connecting the top 25 collaborators of Mahesh Shrestha. A scholar is included among the top collaborators of Mahesh Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahesh Shrestha. Mahesh Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shrestha, Mahesh, Chandra L. Shrestha, Rachael E. Rayner, et al.. (2025). Secondhand vape exposure regulation of CFTR and immune function in cystic fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(3). L324–L333. 1 indexed citations
2.
Bailur, Jithendra Kini, Samuel S. McCachren, Deon B. Doxie, et al.. (2019). Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy. JCI Insight. 4(11). 117 indexed citations
3.
Chaudhri, Virendra K., et al.. (2019). Charting the cis-regulome of activated B cells by coupling structural and functional genomics. Nature Immunology. 21(2). 210–220. 29 indexed citations
4.
Rio‐Machín, Ana, Gonzalo Goméz-López, Javier Muñoz, et al.. (2017). The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia. Leukemia. 31(9). 2000–2005. 23 indexed citations
5.
Lin, Shan, Anetta Ptasinska, Xiaoting Chen, et al.. (2017). A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program. Blood. 130(10). 1213–1222. 26 indexed citations
6.
Goyama, Susumu, Mahesh Shrestha, Wendy R. Miller, et al.. (2016). Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia. Oncogene. 36(18). 2589–2598. 16 indexed citations
7.
Link, Kevin A., Shan Lin, Mahesh Shrestha, et al.. (2016). Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation. Proceedings of the National Academy of Sciences. 113(32). 9075–9080. 13 indexed citations
8.
Shrestha, Mahesh, et al.. (2015). Acute pancreatitis with normal amylase and lipase—an ED dilemma. The American Journal of Emergency Medicine. 34(5). 940.e5–940.e7. 9 indexed citations
9.
Goyama, Susumu, Mahesh Shrestha, Shan Lin, et al.. (2015). UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 30(3). 728–739. 38 indexed citations
10.
Wunderlich, Mark, Benjamin Mizukawa, Fu‐Sheng Chou, et al.. (2013). AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. Blood. 121(12). e90–e97. 71 indexed citations
11.
Chou, Fu‐Sheng, Andrea M. Griesinger, Mark Wunderlich, et al.. (2012). The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO. Blood. 120(4). 709–719. 40 indexed citations
12.
Mizukawa, Benjamin, Jun-Ping Wei, Mahesh Shrestha, et al.. (2011). Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia. Blood. 118(19). 5235–5245. 53 indexed citations
13.
Shrestha, Mahesh, et al.. (1996). Isoetharine versus albuterol for acute asthma: Greater immediate effect, but more side effects. The American Journal of Medicine. 100(3). 323–327. 3 indexed citations
14.
Shrestha, Mahesh, et al.. (1996). Continuous vs Intermittent Albuterol, at High and Low Doses, in the Treatment of Severe Acute Asthma in Adults. CHEST Journal. 110(1). 42–47. 62 indexed citations
15.
Shrestha, Mahesh, et al.. (1996). A comparison of three gastric lavage methods using the radionuclide gastric emptying study. Journal of Emergency Medicine. 14(4). 413–418. 6 indexed citations
16.
Shrestha, Mahesh, et al.. (1996). Metered-dose inhaler technique of patients in an urban ED: Prevalence of incorrect technique and attempt at education. The American Journal of Emergency Medicine. 14(4). 380–384. 62 indexed citations
17.
Shrestha, Mahesh, et al.. (1995). Randomized Double-Blind Comparison of the Analgesic Efficacy of Intramuscular Ketorolac and Oral Indomethacin in the Treatment of Acute Gouty Arthritis. Annals of Emergency Medicine. 26(6). 682–686. 80 indexed citations
18.
Shrestha, Mahesh, et al.. (1994). Treatment of acute gouty arthritis with intramuscular ketorolac tromethamine. The American Journal of Emergency Medicine. 12(4). 454–455. 9 indexed citations
19.
20.
Steere, Allen C., et al.. (1985). Recovery of Lyme disease spirochetes from patients.. PubMed. 57(4). 557–60. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Passos Breakdown of academic impact, for papers by Takanobu Kurashige Breakdown of academic impact, for papers by Víctor Llorenç Breakdown of academic impact, for papers by Guadalupe Hernández‐Pacheco Breakdown of academic impact, for papers by Herbert B. Lindsley Breakdown of academic impact, for papers by Caroline A. Lindemans Breakdown of academic impact, for papers by Deniz Çağdaş Breakdown of academic impact, for papers by J.M. Garnier Breakdown of academic impact, for papers by Ismé de Kleer Breakdown of academic impact, for papers by Donna Smith
Rankless by CCL
2026